Absorption, distribution, metabolism, and excretion of ateverdine in the rat

Drug Metabolism and Disposition

Volumn 26, Issue 10, 1998, Pages 1008-1018

  Chang, Mayland ^a   Sood, Virendra K ^b   Wilson, Gracella J ^b   Kloosterman, David A ^b   Sanders, Phillip E ^b   Schuette, Margaret R ^b   Judy, Ray W ^b   Voorman, Richard L ^b   Maio, Stephen M ^b   Slatter, J Greg ^b  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATEVIRDINE MESYLATE; CARBON 14; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FECES LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MALE; MASS SPECTROMETRY; MICROSOMES; PIPERAZINES; PREGNANCY; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE INHIBITORS; TISSUE DISTRIBUTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031784926     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Althaus IW, Chou JJ, Gonzales AJ, Deibel MR, Chou KC, Kezdy FJ, Romero DL, Aristoff PA, Tarpley WG and Reusser F (1993) Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E. J Biol Chem 268:6119-6124.
2. Anstadt RA, Schwende FJ, Sedlock ML, Voorman RL and Wurzer GM (1991) Preclinical pharmacokinetic evaluation of several bisheteroarylpiperazine (BHAP) analogs, novel non-nucleoside reverse transcriptase inhibitors (RTI). 31st Interscience Conference of Antimicrobial Agents in Chemotherapy (September 29-October 2, Chicago, IL). Abstract 1337.
3. Bax A, Griffey RH and Hawkins BL (1983) Correlation of protein and nitrogen-15 chemical shifts by multiple quantum NMR. J Magn Reson 55:301-315.
4. Bax A and Summers MF (1986) Proton and carbon-13 assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J Am Chem Soc 108:2093-2094.
5. Been-Tiktak AM, Vrehen HM, Schneider MM, Van der Feltz M, Branger T, Ward P, Cox SR, Harry JD and Borleffs JC (1995) Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 39:602-607.
6. Borleffts JCC, Schneider MME, Brehen HM, Branger TM, Ward P, Cox SR and Harry JHD (1992) Safety tolerance and pharmacokinetics of U-87201E in asymptomatic HIV-infected patients. 8th International Conference on AIDS/3rd Sexually Transmitted Disease World Congress, July 19-24, Amsterdam, The Netherlands. Abstract B3010.
7. Campbell TB, Young RK, Eron JJ, D'Aquila RT, Tarpley WG and Kuritzkes DR (1993) Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine. J Infect Dis 168:318-326.
8. Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Hauer MJ and Fagerness PE (1997a) Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats. Drug Metab Dispos 25:228-242.
9. Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Hauer MJ, Zhang W and Branstetter DG (1997b) Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice. Drug Metab Dispos 25:828-839.
10. Cooper KO, Reik LM, Jayyosi Z, Bandiera S, Kelley M, Ryan DE, Daniel R, McCluskey SA, Levin W and Thomas PE (1993) Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch Biochern Biophys 301:345-354.
11. Cox SR, Batts DH, Dietz AJ, Hanover C, Peel BG, Elfring GL and Staton BA (1992) A phase I multiple dose study of U-87201E, a non-nucleoside RT inhibitor in normal healthy males. 8th International Conference on AIDS/3rd Sexually Transmitted Disease World Congress, July 19-24, Amsterdam, The Netherlands. Abstract B1015.
12. Daluge SM, Good SS, Faletto MB, Miller WH, St.Clair MH, Boone LR, Tinsdale M, Parry NR, Reardon JE, Dornsife RE, Averett DR and Krenitsky TA (1997) 1592U89, a novel carbocylic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob Agents Chemother 41:1082-1093.
13. Foye WO (1981) Principles of Medicinal Chemistry, p 97, Lea and Febiger, Philadelphia.
14. Imai Y and Sato R (1974) An affinity column method for partial purification of cytochrome P-450 from phenobarbital-induced rabbit liver microsomes. J Biochem 75:689-697.
15. Redinbaugh MG and Turley RB (1986) Adaptation of the bicinchoninic acid protein assay for use with microtitre plates and sucrose density gradient fractions. Anal Biochem 153:267-276.
16. Reichman RC, Morse GD, Demeter LM, Resnick L, Bassiakos Y, Gischl M, Para M, Powderly W, Leedom J, Greisberger C, Nevin T, Wood K, Meeham PM, Geheb H, Cox S, Batts Timpone J Jr and the ACTG 199 Study Team (1995) Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team. J Infect Dis 171:297-304.
17. Roberts S, Bawdon R, Sobhi S, Dax J, Gilstrap L 3rd and Wimberly D (1995) The maternal-fetal transfer of bisheteroarylpiperazine (U-87201E) in the ex vivo human placenta. Am J Obstet Gynecol 172:88-91.
18. Romero DL, Busso M, Tan CK, Reusser F, Palmer JR, Poppe SM, Aristoff PA, Downey KM, So AG, Resnick L and Tarpley WG (1991) Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 88:8806-8810.
19. Romero DL (1994a) Atevirdine mesylate. Drugs Future 19:9-12.
20. Romero DL (1994b) Delavirdine mesylate. Drugs Future 19:238-242.
21. Romero DL, Morge RA, Biles C, Berrios-Pena N, May PD, Palmer JR, Johnson RD, Smith HW, Busso M, Tan C, Voorman RL, Reusser F, Althaus IW, Downey KM, So AG, Resnick L, Tarpley WG and Aristoff PA (1994) Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitors. J Med Chem 37:999-1014.
22. Romero DL, Morge RA, Genin MJ, Biles C, Busso M, Resnick L, Athaus IW, Reusser F, Thomas RC and Tarpley WG (1993) Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: Structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1-H-indol-2-yl)-carbonyl]-4-[3-[(1-methylethyl-)amino]- pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidate. J Med Chem 36:1505-1508.
23. Rosser LM, O'Donnell AM, Lee KM and Morse GD (1994) In vitro protein-binding characteristics of atevirdine and its N-dealkylated metabolite. Antiviral Res 25:193-200.
24. Shaka AJ, Barker PB and Freeman RJ (1985) Computer-optimized decoupling scheme for wideband applications and low-level operation. J Magn Reson 64:547-552.
25. The Upjohn Company (1993) Atevirdine mesylate (U-87201E) investigator brochure. Kalamazoo, MI.
26. The Upjohn Company (1995) Delavirdine mesylate (U-90152S) investigator brochure. Kalamazoo, MI.
27. Tsuzuki N, Hama T, Kawada M, Hasui A, Konishi R, Shiwa S, Ochi Y, Futaki S and Kitagawa K (1994) Adamantane as a brain-directed drug carrier for poorly absorbed drug. 2. AZT derivatives conjugated with the 1-adamantane moiety. J Pharm Sci 83:481-484.
28. vanderHoeven TA and Coon MJ (1974) Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. J Biol Chem 249:6302-6310.
29. Ward PS, Cox SR, Staton BA, Harry JD, Oliver S, Keedy F and Potuszynskyj A (1992) Escalating, single dose, safety, tolerance and pharmacokinetics of U-87201E in healthy male volunteers. 8th International Conference on AIDS/3rd Sexually Transmitted Disease World Congress, July 19-24, Amsterdam, The Netherlands. Abstract B3032.
30. Zimmerman TP, Mahony WB and Prus KL (1987) 3′-Azido-3′-deoxythymidine - an unusual analog that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. J Biol Chem 262:5748-5754.